Revvity: Dawn score and attention ranking
Revvity scores 46 out of 100 on the Dawn Index, built from 4 signals. It ranks #14 of 15 in Health Care Equipment (S&P 500), #47 of 57 in Health Care (S&P 500), #314 of 455 in S&P 500.
What drives the Revvity Dawn score?
| Signal | Weight | Score (0 to 100) |
|---|---|---|
| Search scale | 20% | 39 |
| Search momentum | 20% | 45 |
| Site scale | 15% | 40 |
| Site momentum | 10% | 62 |
How does Revvity compare in Health Care Equipment (S&P 500)?
| Rank | Brand | Dawn score |
|---|---|---|
| 1 | Stryker Corporation | 64 |
| 2 | Abbott Laboratories | 59 |
| 3 | Dexcom | 56 |
| 4 | Becton Dickinson | 54 |
| 5 | Medtronic | 54 |
| 6 | ResMed | 53 |
| 7 | Boston Scientific | 50 |
| 8 | Edwards Lifesciences | 49 |
Where do the numbers come from?
Search figures are Google search estimates for the brand and its products. Site figures are third-party traffic estimates. A Dawn score measures attention, not revenue.